Michael Mithoefer, MD, is a psychiatrist living in Asheville, NC.  He and his wife, Annie, completed the first MAPS-sponsored Phase Il clinical trial testing MDMA-assisted psychotherapy for crime-related PTSD, a subsequent study with military veterans, firefighters and police officers, and a pilot study treating couples with MDMA combined with Cognitive Behavioral Conjoint Therapy for PTSD. He has been Medical Monitor for a series of six MAPS-sponsored Phase 2 trials in the US, Canada, Switzerland and Israel, which produced data that led to breakthrough therapy designation by the FDA. Since 2012 he and Annie have conducted training for research therapists, and supervising therapists in ongoing MAPS clinical trials, as well as training and mentoring new MAPS trainers and supervisors. He received his MD degree from the Medical University of South Carolina (MUSC) and completed residency trainings in Internal Medicine at the University of Virginia and Psychiatry at MUSC. He is a certified Grof Holotropic Breathwork facilitator, and is trained in Internal Family Systems Therapy and EMDR. He has been board certified in Psychiatry, Emergency Medicine and Internal Medicine. He is a Fellow of the American Psychiatric Association, Affiliate Assistant Professor at MUSC and Clinical Assistant Professor of Psychiatry at Columbia University..